A B O U T     EDI

Lena Gray, P.T. &

Baby Development Expert

Empire Discovery Institute and Deerfield Management Launch Empire-Deerfield Discovery & Development (ED3) LLC

A B O U T   E D 3

Deerfield Management Company and the Empire Discovery Institute (EDI) have formed a translational research partnership to accelerate the development of novel therapeutics.  Through the partnership Deerfield expects to invest up to $65 million over the next five years to translate scientific discoveries with potential applications for patients.

Through a newly launched company called Empire Deerfield Discovery & Development LLC (ED3 ), funding and support will be available for projects in high-need therapeutic areas, as well as those targeting patients who suffer from hard-to-treat and rare diseases, to accelerate them towards clinical validation in patients and commercialization. 


Advancing Healthcare

Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.


Transforming Discoveries into Medicines

EDI is a non-profit New York drug discovery and development accelerator created to translate important academic discoveries into new medicines for commercialization by providing strategic support and pharmaceutical development expertise. The EDI works in partnership with research labs at the University of Rochester, the University at Buffalo, and Roswell Park Comprehensive Cancer Center. 

logo final_.png